Commercial Viability Offerings

The Commercial Viability Academy is an exclusive, invitation-only program for founders and investors presented by RQR Advisors. This hands-on Academy educates founders and investors in new life science technologies on how Commercial Viability (“CV”) influences product development, investor confidence, and strategic acquisition.

Using real-world case studies, the Academy shows how commercial logic – not just technical milestones – determines the exit. 

The Academy offers unparalleled access to former multinational executives, corporate development leaders, and cross-functional subject matter experts, all working together as they did inside Strategics.

It is designed for founders who value clarity before commitment and who desire fewer slide presentations and more interactive dialogue and debate.  Attendees leave the Academy with a draft roadmap for focusing on their next moves in product development, fundraising, and partnerships and for what steps not to take in the process.

Learn More and Preregister

Commercial Viability Assessment (CVA) is a bespoke engagement where the Council develops a board-ready exit plan and a defined Commercial Viability Roadmap focused on value enhancement

The CVA is a fixed-fee, 3–4-month, market-access-driven engagement that typically focuses on the client’s market entry and strategic portfolio alignment.  During the CVA process, we analyze in detail the 7 Domains of Commercial Quotient™ and advise the client on strategy and levers for increasing value across these domains. 

The scope of this engagement includes an assessment of relevant market dynamics and drivers, target vertical applicability, physician workflow considerations, procedural and site-of-service economics, potential barriers to adoption, the competitive landscape for new entrants, and alignment with the portfolios of potential strategic partners or acquirers – all in an interdependent, integrated, and comprehensive fashion.

Our methodology leverages our Commercial Viability Council of subject matter experts, executive leadership team, and proprietary market intelligence across the healthcare value chain, gained through decades of experience at multinational strategic companies and our longstanding relationships throughout the industry.

Our approach combines comprehensive market analysis with real-world validation through direct stakeholder engagement—ensuring recommendations are both strategically sound and practically executable.

Contact Us to Learn More

With certain clients, RQR Advisors partners with the client following the completion of a CVA in a Commercial Viability Partnership(“CVP”), which is a bespoke engagement focused on providing board-level guidance, recommendations, decision making, subject-matter review process, and stakeholder (potential strategic acquirers and investors) introductions and presentations to successfully realize a commercial exit and achieve maximum value.

In addition to ongoing advisement and support with the domains covered in a CVA, the CVP also provides much greater product viability support through all critical stages of the product development and clinical lifecycle. 

The CVP duration typically runs from project inception through a successful commercial outcome. The compensation structure is a combination of cash and equity, with the equity portion designed to further align our interests with the company’s.